The EAU regularly publishes press releases. Other news can be found in the News section or in the EAU News mailing. Stay up to date, and subscribe to the EAU Press Mailing List to receive the latest EAU press releases and other relevant information. Please subscribe here.
The most comprehensive study so far conducted, from over 30,000 patients in the Danish Cancer Registry, give support to the idea that statin use causes a reduction in mortality after prostate cancer. This work is presented at the 31st Annual EAU Congress in Munich.
A study on non-coding RNA (Ribonucleic Acid) from prostate cancer patients has identified a series of new prostate cancer markers which can be found in urine. Combining these RNA markers into a single test potentially opens the door for simple, accurate non-invasive testing for prostate cancer.
A new Europe-wide survey shows significant country-to-country differences in rates of kidney transplant donors. The survey shows for example within the EU, there is a x5 variation in the number of kidney donors per country (per head of population). This variation is probably due to different legal and social standards across Europe.
Prostate cancer is the most common male cancer, with 400,000 new cases every year in Europe. The success of surgery depends on a variety of factors. Now a new study from scientists in Milan has shown that for local prostate cancers treated with radical prostatectomy, you can preoperatively predict the aggressiveness of the prostatic disease, via a simple blood test.
Recent studies have indicated that patients with sleep apnea may be associated with worse cancer outcomes. Now a new animal study, presented at the Annual Congress of the European Association of Urology in Munich, uncovers a possible mechanism which may underlie this link.
Men with fertility problems are at risk of metabolic diseases as they age, according to work being presented at the Annual Congress of the European Association of Urology in Munich*.
Around fifteen percent of all couples experience infertility, and in around half of these cases this is due to male infertility. Men with poor semen quality have been shown to have a decreased life expectancy, but the cause are unknown and no biochemical markers or prevention strategies have been developed. Now a group of Swedish researchers have measured the levels of sex hormones and other biochemical parameters in infertile men, and have shown that many of them are at risk of hypogonadism (low levels of sex hormones) as well as signs of metabolic disease and osteoporosis.
Madrid, 23 March 2015 – Initial results from the Göteborg randomised screening trial indicates that using MRI (Magnetic Resonance Imaging) alongside conventional prostate cancer screening seems to offer improved cancer detection and can help avoid unnecessary biopsies.
Madrid, 23 March 2015 – Incontinence is a common side-effect in men after treatment for prostate cancer. Now a new study not only confirms the high rates of post-operation incontinence, but also for the first time details some of the significant economic costs facing men – on average €210 per year after surgery, in some cases rising to as much as €283 in the first year. This work is presented at the European Association of Urology conference in Madrid.
Madrid, 22 March 2015 – Does age affect the outcomes of men after radical prostatectomy for high-risk prostate cancer? Does a long post-operative cancer specific survival make a difference in outcomes in such patients? A major new study suggests that both the age of the patient and the time survived since the operation have a significant impact in terms of cause of death. In practical terms this means that, for young men with high-risk prostate cancer, doctors may have to re-evaluate long-term clinical priorities with increasing time since surgery. This study is being presented at the European Association of Urology conference in Madrid.
Madrid, 22 March 2015 – Regaining normal erectile function is rare after the most common prostate operation, radical prostatectomy. This is the main result of a new study which is presented at the European Association of Urology Congress in Madrid.